Signature Estate & Investment Advisors LLC Makes New $210,000 Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

Signature Estate & Investment Advisors LLC bought a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 525 shares of the biotechnology company’s stock, valued at approximately $210,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Foundations Investment Advisors LLC bought a new position in Axon Enterprise during the 3rd quarter worth $221,000. Sequoia Financial Advisors LLC increased its holdings in shares of Axon Enterprise by 4.9% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after acquiring an additional 81 shares during the period. Axxcess Wealth Management LLC acquired a new position in Axon Enterprise during the 3rd quarter valued at about $814,000. Jag Capital Management LLC grew its position in Axon Enterprise by 9.7% in the 3rd quarter. Jag Capital Management LLC now owns 56,086 shares of the biotechnology company’s stock worth $22,412,000 after purchasing an additional 4,954 shares during the last quarter. Finally, Versor Investments LP acquired a new stake in shares of Axon Enterprise in the third quarter valued at approximately $651,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Trading Down 0.9 %

Shares of NASDAQ AXON opened at $599.35 on Friday. The business has a fifty day simple moving average of $438.79 and a 200-day simple moving average of $357.57. The company has a market cap of $45.70 billion, a price-to-earnings ratio of 154.87, a P/E/G ratio of 15.05 and a beta of 0.94. Axon Enterprise, Inc. has a 12 month low of $220.78 and a 12 month high of $624.84. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Insiders Place Their Bets

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $373.03, for a total value of $167,863.50. Following the completion of the sale, the director now directly owns 7,379 shares of the company’s stock, valued at $2,752,588.37. This represents a 5.75 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Julie A. Cullivan sold 900 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $353.53, for a total transaction of $318,177.00. Following the completion of the transaction, the director now owns 3,653 shares in the company, valued at approximately $1,291,445.09. This represents a 19.77 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 411,006 shares of company stock worth $161,360,618 over the last ninety days. 6.10% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the company. Northland Securities increased their price objective on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. JMP Securities lifted their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. Needham & Company LLC increased their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Finally, Barclays raised their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $427.83.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.